Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
Identifieur interne : 001730 ( Ncbi/Merge ); précédent : 001729; suivant : 001731Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
Auteurs : Aline Gronchi-Perrin [Suisse] ; Sarah Viollier ; Joseph Ghika ; Pierre Combremont ; Jean-Guy Villemure ; Julien Bogousslavsky ; Pierre R. Burkhard ; François VingerhoetsSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2006.
English descriptors
- KwdEn :
- Activities of Daily Living (psychology), Aged, Antiparkinson Agents (therapeutic use), Deep Brain Stimulation (psychology), Female, Humans, Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (physiopathology), Parkinson Disease (psychology), Parkinson Disease (rehabilitation), Prospective Studies, Quality of Life (psychology), Retrospective Studies, Subthalamic Nucleus (physiopathology).
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- physiopathology : Parkinson Disease, Subthalamic Nucleus.
- psychology : Activities of Daily Living, Deep Brain Stimulation, Parkinson Disease, Quality of Life.
- rehabilitation : Parkinson Disease.
- Aged, Female, Humans, Male, Middle Aged, Prospective Studies, Retrospective Studies.
Abstract
We investigated the impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of life (QOL) in patients with advanced Parkinson's disease, as self-assessed before and after surgery by completing the Parkinson's Disease Questionnaire (PDQ39). In addition to this prospective evaluation, we asked patients postoperatively to evaluate their preoperative QOL. In the prospective assessment, results showed that patients perceived a general improvement of QOL after the STN DBS. However, when evaluated retrospectively, they tended to overestimate their preoperative functioning, therefore obscuring the improvement found prospectively. This observation highlights the impact of the method used on obtained results when assessing the effects of STN DBS.
DOI: 10.1002/mds.20943
PubMed: 16763974
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002C06
- to stream PubMed, to step Curation: 002C06
- to stream PubMed, to step Checkpoint: 002D70
Links to Exploration step
pubmed:16763974Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?</title><author><name sortKey="Gronchi Perrin, Aline" sort="Gronchi Perrin, Aline" uniqKey="Gronchi Perrin A" first="Aline" last="Gronchi-Perrin">Aline Gronchi-Perrin</name><affiliation wicri:level="3"><nlm:affiliation>Vaud-Geneva Deep Brain Stimulation Program for Movement Disorders, CHUV, Lausanne, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Vaud-Geneva Deep Brain Stimulation Program for Movement Disorders, CHUV, Lausanne</wicri:regionArea><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation></author><author><name sortKey="Viollier, Sarah" sort="Viollier, Sarah" uniqKey="Viollier S" first="Sarah" last="Viollier">Sarah Viollier</name></author><author><name sortKey="Ghika, Joseph" sort="Ghika, Joseph" uniqKey="Ghika J" first="Joseph" last="Ghika">Joseph Ghika</name></author><author><name sortKey="Combremont, Pierre" sort="Combremont, Pierre" uniqKey="Combremont P" first="Pierre" last="Combremont">Pierre Combremont</name></author><author><name sortKey="Villemure, Jean Guy" sort="Villemure, Jean Guy" uniqKey="Villemure J" first="Jean-Guy" last="Villemure">Jean-Guy Villemure</name></author><author><name sortKey="Bogousslavsky, Julien" sort="Bogousslavsky, Julien" uniqKey="Bogousslavsky J" first="Julien" last="Bogousslavsky">Julien Bogousslavsky</name></author><author><name sortKey="Burkhard, Pierre R" sort="Burkhard, Pierre R" uniqKey="Burkhard P" first="Pierre R" last="Burkhard">Pierre R. Burkhard</name></author><author><name sortKey="Vingerhoets, Francois" sort="Vingerhoets, Francois" uniqKey="Vingerhoets F" first="François" last="Vingerhoets">François Vingerhoets</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="doi">10.1002/mds.20943</idno><idno type="RBID">pubmed:16763974</idno><idno type="pmid">16763974</idno><idno type="wicri:Area/PubMed/Corpus">002C06</idno><idno type="wicri:Area/PubMed/Curation">002C06</idno><idno type="wicri:Area/PubMed/Checkpoint">002D70</idno><idno type="wicri:Area/Ncbi/Merge">001730</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?</title><author><name sortKey="Gronchi Perrin, Aline" sort="Gronchi Perrin, Aline" uniqKey="Gronchi Perrin A" first="Aline" last="Gronchi-Perrin">Aline Gronchi-Perrin</name><affiliation wicri:level="3"><nlm:affiliation>Vaud-Geneva Deep Brain Stimulation Program for Movement Disorders, CHUV, Lausanne, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Vaud-Geneva Deep Brain Stimulation Program for Movement Disorders, CHUV, Lausanne</wicri:regionArea><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation></author><author><name sortKey="Viollier, Sarah" sort="Viollier, Sarah" uniqKey="Viollier S" first="Sarah" last="Viollier">Sarah Viollier</name></author><author><name sortKey="Ghika, Joseph" sort="Ghika, Joseph" uniqKey="Ghika J" first="Joseph" last="Ghika">Joseph Ghika</name></author><author><name sortKey="Combremont, Pierre" sort="Combremont, Pierre" uniqKey="Combremont P" first="Pierre" last="Combremont">Pierre Combremont</name></author><author><name sortKey="Villemure, Jean Guy" sort="Villemure, Jean Guy" uniqKey="Villemure J" first="Jean-Guy" last="Villemure">Jean-Guy Villemure</name></author><author><name sortKey="Bogousslavsky, Julien" sort="Bogousslavsky, Julien" uniqKey="Bogousslavsky J" first="Julien" last="Bogousslavsky">Julien Bogousslavsky</name></author><author><name sortKey="Burkhard, Pierre R" sort="Burkhard, Pierre R" uniqKey="Burkhard P" first="Pierre R" last="Burkhard">Pierre R. Burkhard</name></author><author><name sortKey="Vingerhoets, Francois" sort="Vingerhoets, Francois" uniqKey="Vingerhoets F" first="François" last="Vingerhoets">François Vingerhoets</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activities of Daily Living (psychology)</term><term>Aged</term><term>Antiparkinson Agents (therapeutic use)</term><term>Deep Brain Stimulation (psychology)</term><term>Female</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson Disease (psychology)</term><term>Parkinson Disease (rehabilitation)</term><term>Prospective Studies</term><term>Quality of Life (psychology)</term><term>Retrospective Studies</term><term>Subthalamic Nucleus (physiopathology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term><term>Subthalamic Nucleus</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Activities of Daily Living</term><term>Deep Brain Stimulation</term><term>Parkinson Disease</term><term>Quality of Life</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Retrospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We investigated the impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of life (QOL) in patients with advanced Parkinson's disease, as self-assessed before and after surgery by completing the Parkinson's Disease Questionnaire (PDQ39). In addition to this prospective evaluation, we asked patients postoperatively to evaluate their preoperative QOL. In the prospective assessment, results showed that patients perceived a general improvement of QOL after the STN DBS. However, when evaluated retrospectively, they tended to overestimate their preoperative functioning, therefore obscuring the improvement found prospectively. This observation highlights the impact of the method used on obtained results when assessing the effects of STN DBS.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">16763974</PMID><DateCreated><Year>2006</Year><Month>09</Month><Day>27</Day></DateCreated><DateCompleted><Year>2007</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>9</Issue><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?</ArticleTitle><Pagination><MedlinePgn>1465-8</MedlinePgn></Pagination><Abstract><AbstractText>We investigated the impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of life (QOL) in patients with advanced Parkinson's disease, as self-assessed before and after surgery by completing the Parkinson's Disease Questionnaire (PDQ39). In addition to this prospective evaluation, we asked patients postoperatively to evaluate their preoperative QOL. In the prospective assessment, results showed that patients perceived a general improvement of QOL after the STN DBS. However, when evaluated retrospectively, they tended to overestimate their preoperative functioning, therefore obscuring the improvement found prospectively. This observation highlights the impact of the method used on obtained results when assessing the effects of STN DBS.</AbstractText><CopyrightInformation>(c) 2006 Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gronchi-Perrin</LastName><ForeName>Aline</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vaud-Geneva Deep Brain Stimulation Program for Movement Disorders, CHUV, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viollier</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ghika</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Combremont</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Villemure</LastName><ForeName>Jean-Guy</ForeName><Initials>JG</Initials></Author><Author ValidYN="Y"><LastName>Bogousslavsky</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Burkhard</LastName><ForeName>Pierre R</ForeName><Initials>PR</Initials></Author><Author ValidYN="Y"><LastName>Vingerhoets</LastName><ForeName>François</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000203">Activities of Daily Living</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D046690">Deep Brain Stimulation</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000534">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D020531">Subthalamic Nucleus</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>6</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>6</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1002/mds.20943</ArticleId><ArticleId IdType="pubmed">16763974</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Suisse</li></country><region><li>Canton de Vaud</li></region><settlement><li>Lausanne</li></settlement></list><tree><noCountry><name sortKey="Bogousslavsky, Julien" sort="Bogousslavsky, Julien" uniqKey="Bogousslavsky J" first="Julien" last="Bogousslavsky">Julien Bogousslavsky</name><name sortKey="Burkhard, Pierre R" sort="Burkhard, Pierre R" uniqKey="Burkhard P" first="Pierre R" last="Burkhard">Pierre R. Burkhard</name><name sortKey="Combremont, Pierre" sort="Combremont, Pierre" uniqKey="Combremont P" first="Pierre" last="Combremont">Pierre Combremont</name><name sortKey="Ghika, Joseph" sort="Ghika, Joseph" uniqKey="Ghika J" first="Joseph" last="Ghika">Joseph Ghika</name><name sortKey="Villemure, Jean Guy" sort="Villemure, Jean Guy" uniqKey="Villemure J" first="Jean-Guy" last="Villemure">Jean-Guy Villemure</name><name sortKey="Vingerhoets, Francois" sort="Vingerhoets, Francois" uniqKey="Vingerhoets F" first="François" last="Vingerhoets">François Vingerhoets</name><name sortKey="Viollier, Sarah" sort="Viollier, Sarah" uniqKey="Viollier S" first="Sarah" last="Viollier">Sarah Viollier</name></noCountry><country name="Suisse"><region name="Canton de Vaud"><name sortKey="Gronchi Perrin, Aline" sort="Gronchi Perrin, Aline" uniqKey="Gronchi Perrin A" first="Aline" last="Gronchi-Perrin">Aline Gronchi-Perrin</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001730 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001730 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:16763974
|texte= Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:16763974" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |